Ajanta Pharma Ltd.

NSE: AJANTPHARM | BSE: 532331 | ISIN: INE031B01049 | Industry: Pharmaceuticals
| Turnaround Potential

logo
Ajanta Pharma Ltd.
06 May 2026
3035.00
-1.41%
ICICI Direct
Branded generics traction, US momentum key differentiators- Branded business growth in India was significantly above the trendline and without one-offs, driven by 26 new launches over the last 12 months and improved coverage. The US also maintained the growth tempo on account of 8 new launches over the last 15 months and market share gain in the existing products. US traction is contrary to the existing industry trend as the focus remains on specific launches. Africa branded continued to be driven by new launch. Asia branded witnessed negative growth due to geopolitical...
ICICI Direct increased Buy price target of Ajanta Pharma Ltd. to 3520.0 on 06 May, 2026.
More from Ajanta Pharma Ltd.
Recommended